Article
The FDA is weighing the application by Amphastar Pharmaceuticals Inc. for a hyaluronidase injection 150 units/ml, 1ml.
AAO 2024: Ocular imaging in the emergency department can provide timely, accurate diagnosis
Innovation Series: Expanding access to eye care, advice for aspiring innovators from DMEI ophthalmology residents (part 3)
Researchers receive $6.4 million grant from NEI to seek new treatment for blindness-causing diseases
Innovation Series: How DMEI residents are shaping the future with smartphone imaging for retinal care (part 2)
Cerebral visual impairment: A growing concern in pediatric vision loss
AI-related innovations for laser cataract technology mark a milestone in history of device